Phosphatidic acid and tumor necrosis factor-alpha induce the expression of CD83 through mitogen activated protein kinase pathway in a CD34+ hematopoietic progenitor cell line, KG1.
Kim
Ja-Woong
JW
Medical Research Center for Cancer Molecular Therapy, College of Medicine, Dong-A University, Busan 602-714, South Korea.
Park
Hae-Young
HY
Lee
Min-Jung
MJ
Jang
Min-Jung
MJ
Lee
Sun-Young
SY
Park
Yeong-Min
YM
Son
Dong-Hoon
DH
Chang
Young-Chae
YC
Bae
Yoe-Sik
YS
Kwak
Jong-Young
JY
D015703:Antigens, CD; D018952:Antigens, CD34 / Q000187:drug effects* / Q000378:metabolism; D039521:CD11c Antigen / Q000235:genetics / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D045744:Cell Line, Tumor; D003713:Dendritic Cells / Q000187:drug effects / Q000378:metabolism; D004338:Drug Combinations; D005419:Flavonoids / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007136:Immunoglobulins / Q000187:drug effects / Q000235:genetics*; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism; D007723:Korea; D008562:Membrane Glycoproteins / Q000187:drug effects / Q000235:genetics*; D020929:Mitogen-Activated Protein Kinase Kinases / Q000378:metabolism*; D010712:Phosphatidic Acids / Q000494:pharmacology*; D010739:Phospholipase D / Q000378:metabolism / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects / Q000235:genetics*; D000097802:CD83 Antigen
D015703:Antigens, CD; D018952:Antigens, CD34; D039521:CD11c Antigen; D004338:Drug Combinations; D005419:Flavonoids; D007136:Immunoglobulins; D048031:JNK Mitogen-Activated Protein Kinases; D008562:Membrane Glycoproteins; D020929:Mitogen-Activated Protein Kinase Kinases; D010712:Phosphatidic Acids; D010739:Phospholipase D; D014409:Tumor Necrosis Factor-alpha; D000097802:CD83 Antigen; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one